XML 66 R27.htm IDEA: XBRL DOCUMENT
v2.4.0.8

INTANGIBLE ASSETS (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of intangible assets | The following table sets forth the gross carrying amount and accumulated amortization of our intangible assets as of September 30, 2014 and December 31, 2013:
|  | September 30, 2014
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Amount |  | Weighted- Average Remaining Amortization Period (yrs.)
Amortizing intangible assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
OPERA® software patent |  | $ | 31,951 |  |  | $ | (1,997 | ) |  | $ | 29,954 |  |  |  | 15 |
Development costs of |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
corporate website |  |  | 91,743 |  |  |  | (91,743 | ) |  |  | — |  |  |  | n/a |
Approved hormone |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
therapy drug |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
candidate patents |  |  | 387,806 |  |  |  | (13,616 | ) |  |  | 374,190 |  |  |  | 18.25 |
Non-amortizing intangible |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Hormone therapy drug |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
candidate patents |  |  | 340,059 |  |  |  | — |  |  |  | 340,059 |  |  |  | n/a |
(pending) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Multiple trademarks for |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
vitamins/supplements |  |  | 97,538 |  |  |  | — |  |  |  | 97,538 |  |  |  | n/a |
Total |  | $ | 949,097 |  |  | $ | (107,356 | ) |  | $ | 841,741 |  |  |  |  |
|  | December 31, 2013
|  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Amount |  | Weighted- Average Remaining Amortization Period (yrs.)
Amortizing intangible assets: |  |  |  |  |  |  |  |
OPERA® software patent |  | $ | 31,951 |  |  | $ | (499 | ) |  | $ | 31,452 |  |  |  | 15.8 |
Development costs of |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
corporate website |  |  | 91,743 |  |  |  | (89,661 | ) |  |  | 2,082 |  |  |  | 0.3 |
Non-amortizing intangible |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Hormone therapy drug |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
candidate patents (pending) |  |  | 572,726 |  |  |  | — |  |  |  | 572,726 |  |  |  | n/a |
Multiple trademarks for |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
vitamins/supplements |  |  | 59,328 |  |  |  | — |  |  |  | 59,328 |  |  |  | n/a |
Total |  | $ | 755,748 |  |  | $ | (90,160 | ) |  | $ | 665,588 |  |  |  |  |
Schedule of estimated amortization expense | Amortization expense was $5,625 and $3,255 for the three months ended September 30, 2014 and 2013, respectively and $17,196 and $9,764 for the nine months ended September 30, 2014 and 2013, respectively. Estimated amortization expense for the next five years is as follows:
Year Ending December 31, |  | Estimated Amortization
2014 (3 months) |  | $5,625
2015 |  | $22,500
2016 |  | $22,500
2017 |  | $22,500
2018 |  | $22,500

X
- Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration